We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




New Index Helps Predict Early Death or Hospital Readmission

By HospiMedica International staff writers
Posted on 24 Mar 2010
A new tool can assist physicians predict the likelihood of death or readmission to hospital for patients within 30 days of discharge, claims a new study.

Researchers at the Ottawa Hospital Research Institute (OHRI; ON, Canada), the University of Ottawa (ON, Canada), and other institutions followed 4,812 patients admitted to 11 Ontario hospitals between October 2002 and July 2006. More...
The participants were middle-aged, almost 95% were independent in daily living routines, and most were free of comorbidities; none of the participants were residents of nursing homes. The most common reasons for hospitalization were acute coronary syndromes (ACS), cancer diagnoses and complications, and heart failure. During the first 30 days after discharge from hospital, 8% (385) of the patients died or were urgently readmitted; of these, 9.4% (36) died and 90.4% (349) had unplanned readmissions.

The researchers found that the key factors associated with these events were length of stay (L), acuity of admission (A), patient comorbidity (C), and number of visits to the emergency room (E). From these factors, the researchers derived the LACE index for easy recall, which has a potential score of 0 (2% expected risk of death or urgent readmission within 30 days) to 19 (43.7% expected risk). The researchers warn, however, that though the index tool is easy to use, it is difficult to memorize and necessitates a computational aid. By using the LACE index, clinicians can quantify the risk of early death or unplanned readmission after discharge, and the tool could also be useful in focusing post-discharge support on patients that show the highest risk of poor outcomes. The index was externally validated using administrative data in a random selection of 1,000,000 citizens of Ontario (Canada) discharged from hospitals between 2004 and 2008. The study was published ahead of print on March 8, 2010, in the Canadian Medical Association Journal (CMAJ).

"We believe that the LACE index can be used by clinicians, researchers and administrators to predict the risk of early death or unplanned readmission of cognitively intact medical or surgical patients after discharge from the hospital to the community,” concluded lead author Carl Van Walraven, M.D., of the OHRI, and colleagues. "We have derived and validated an easy-to-use index that is moderately discriminative and very accurate for predicting the risk of early death or unplanned readmission after discharge from hospital to the community.”

Related Links:
Ottawa Hospital Research Institute
University of Ottawa



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Electric Bed
DIXION Intensive Care Bed
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.